Bitdeer BTDR Sold All its Bitcoin
Bitdeer Technologies Group BTDR reported on Friday that has liquidated its entire BTC treasury, after selling 189.8 BTC that the company produced during the reporting period.
Doordash DASH Surge in Premarket Trading
DoorDash DASH shares trade11.74% higher at $194.10 in premarket trading, despite mixed results for the Q4 that missed analysts’ expectations.
Why Palo Alto Networks’ PANW is Down Today?
Palo Alto Networks’ PANW reported earnings better than expected for the quarter. In premarket trading, PANW stock is trading 6.76% lower at $152.44 as the company cut its full-year earnings outlook.
Ocular Therapeutix OCUL Stock Rallies
Ocular Therapeutix OCUL stock trades 30% higher at $11.56 in premarket trading as traders and investors are highly optimistic ahead of the company’s scheduled 8:00 a.m. ET
Here is why Dogecoin DOGE surge
Dogecoin (DOGE) price surged, with gains over18%, pushing the price from around $0.097 to approximately $0.1170. The main drivers behind
Silver Price Rollercoaster: Analyzing the Crash and Rebound
The silver market in the first trading days of February 2026 is showing high volatility after an extreme run-up in late 2025 and January 2026. Silver opened 2025 near $29 and ended the year above $70 per ounce.
Transocean RIG acquires Valaris VAL
Transocean Ltd. (RIG) announced this morning that it has entered into an agreement to acquire Valaris Limited (VAL) in an all-stock transaction valued at approximately $5.8 billion
Gemini GEMI Soars After CFTC Aproval for Prediction Markets
Gemini GEMI trades 16% higher after Gemini’s affiliate, Gemini Titan, received a Designated Contract Market (DCM) license from the CFTC.
Here is Why Enveric Biosciences ENVB Rallies Today
Enveric Biosciences Inc ENVB trades 95% higher today after the U.S. Patent and Trademark Office (USPTO) issued a Notice of Allowance for a new patent application
Here is why Q/C Technologies QCLS Soars
Q/C Technologies QCLS stock adds over 57% today on volume far above its average. On December 3, 2025, pharma executive Martin Shkreli (known as “Pharma Bro”) posted on X touting QCLS as a “long idea”
Latest Posts
